
Kevin S. Orwig
Examiner (ID: 6462, Phone: (571)270-5869 , Office: P/1611 )
| Most Active Art Unit | 1611 |
| Art Unit(s) | 1611, 3991, 1658 |
| Total Applications | 903 |
| Issued Applications | 255 |
| Pending Applications | 44 |
| Abandoned Applications | 609 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 16252160
[patent_doc_number] => 20200261534
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => NEW TREATMENTS OF MULTIPLE MYELOMA
[patent_app_type] => utility
[patent_app_number] => 16/651983
[patent_app_country] => US
[patent_app_date] => 2018-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 19204
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 324
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16651983
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/651983 | NEW TREATMENTS OF MULTIPLE MYELOMA | Sep 9, 2018 | Abandoned |
Array
(
[id] => 16268822
[patent_doc_number] => 20200270309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-27
[patent_title] => MALEIMIDE GROUP-MODIFIED ANGIOGENESIS INHIBITOR HM-1 AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/646576
[patent_app_country] => US
[patent_app_date] => 2018-09-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34438
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 40
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16646576
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/646576 | MALEIMIDE GROUP-MODIFIED ANGIOGENESIS INHIBITOR HM-1 AND USE THEREOF | Sep 6, 2018 | Abandoned |
| 16/120549 | GROWTH DIFFERENTIATION FACTOR 11 (GDF-11) FOR TREATMENT OF DIASTOLIC HEART FAILURE | Sep 3, 2018 | Pending |
Array
(
[id] => 16139113
[patent_doc_number] => 10702610
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-07-07
[patent_title] => Method of making sulfur-containing polymers from hexahydrotriazine and dithiol precursors
[patent_app_type] => utility
[patent_app_number] => 16/116045
[patent_app_country] => US
[patent_app_date] => 2018-08-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 4346
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 93
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16116045
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/116045 | Method of making sulfur-containing polymers from hexahydrotriazine and dithiol precursors | Aug 28, 2018 | Issued |
Array
(
[id] => 16806149
[patent_doc_number] => 20210128702
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-05-06
[patent_title] => USE OF A BOTULINUM TOXIN AGENT FOR TREATING PLASMA CELL DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/635714
[patent_app_country] => US
[patent_app_date] => 2018-08-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9743
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -24
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16635714
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/635714 | USE OF A BOTULINUM TOXIN AGENT FOR TREATING PLASMA CELL DISORDERS | Aug 12, 2018 | Abandoned |
Array
(
[id] => 16376335
[patent_doc_number] => 20200325177
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-15
[patent_title] => METHODS OF MAKING STREPTOGRAMIN COMPOSITIONS AND THE USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/635070
[patent_app_country] => US
[patent_app_date] => 2018-07-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 88270
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16635070
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/635070 | METHODS OF MAKING STREPTOGRAMIN COMPOSITIONS AND THE USE THEREOF | Jul 30, 2018 | Abandoned |
Array
(
[id] => 13549135
[patent_doc_number] => 20180326115
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-15
[patent_title] => FIBRINOGEN-BASED TISSUE ADHESIVE PATCHES
[patent_app_type] => utility
[patent_app_number] => 16/041903
[patent_app_country] => US
[patent_app_date] => 2018-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9430
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16041903
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/041903 | Fibrinogen-based tissue adhesive patches | Jul 22, 2018 | Issued |
Array
(
[id] => 13533773
[patent_doc_number] => 20180318429
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-08
[patent_title] => USE OF HYDROPHOBIC ORGANIC ACIDS TO INCREASE HYDROPHOBICITY OF PROTEINS AND PROTEIN CONJUGATES
[patent_app_type] => utility
[patent_app_number] => 16/032952
[patent_app_country] => US
[patent_app_date] => 2018-07-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9091
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16032952
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/032952 | Use of hydrophobic organic acids to increase hydrophobicity of proteins and protein conjugates | Jul 10, 2018 | Issued |
Array
(
[id] => 13519243
[patent_doc_number] => 20180311164
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-11-01
[patent_title] => TREATING FUNGAL INFECTION OF THE NAIL UNIT
[patent_app_type] => utility
[patent_app_number] => 16/025979
[patent_app_country] => US
[patent_app_date] => 2018-07-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15588
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 59
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16025979
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/025979 | TREATING FUNGAL INFECTION OF THE NAIL UNIT | Jul 1, 2018 | Abandoned |
Array
(
[id] => 15483209
[patent_doc_number] => 10556937
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-11
[patent_title] => Methods for the production of a cosmetic composition comprising leukolectin and uses thereof
[patent_app_type] => utility
[patent_app_number] => 16/010962
[patent_app_country] => US
[patent_app_date] => 2018-06-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 18376
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 110
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16010962
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/010962 | Methods for the production of a cosmetic composition comprising leukolectin and uses thereof | Jun 17, 2018 | Issued |
Array
(
[id] => 15740561
[patent_doc_number] => 20200109168
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-04-09
[patent_title] => MACROCYCLIC PEPTIDES AND DERIVATIVES THEREOF WITH OPIOID ACTIVITY
[patent_app_type] => utility
[patent_app_number] => 16/622749
[patent_app_country] => US
[patent_app_date] => 2018-06-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42526
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16622749
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/622749 | Macrocyclic peptides and derivatives thereof with opioid activity | Jun 14, 2018 | Issued |
Array
(
[id] => 13424771
[patent_doc_number] => 20180263928
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-09-20
[patent_title] => AMANTADINE COMPOSITIONS AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 15/985300
[patent_app_country] => US
[patent_app_date] => 2018-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 29925
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -26
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15985300
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/985300 | AMANTADINE COMPOSITIONS AND METHODS OF USE | May 20, 2018 | Abandoned |
Array
(
[id] => 13729357
[patent_doc_number] => 20180369146
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => METHOD TO PRODUCE A MEDICINAL PRODUCT COMPRISING A BIOLOGICALLY ACTIVE PROTEIN AND THE RESULTING PRODUCT
[patent_app_type] => utility
[patent_app_number] => 15/982287
[patent_app_country] => US
[patent_app_date] => 2018-05-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5709
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15982287
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/982287 | METHOD TO PRODUCE A MEDICINAL PRODUCT COMPRISING A BIOLOGICALLY ACTIVE PROTEIN AND THE RESULTING PRODUCT | May 16, 2018 | Abandoned |
Array
(
[id] => 15553217
[patent_doc_number] => 20200061020
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-02-27
[patent_title] => FORMULATIONS AND COMPOSITIONS OF DOCETAXEL
[patent_app_type] => utility
[patent_app_number] => 16/609592
[patent_app_country] => US
[patent_app_date] => 2018-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52532
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609592
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/609592 | FORMULATIONS AND COMPOSITIONS OF DOCETAXEL | Apr 30, 2018 | Abandoned |
Array
(
[id] => 16053315
[patent_doc_number] => 20200188512
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-06-18
[patent_title] => ADJUVANT COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 16/609136
[patent_app_country] => US
[patent_app_date] => 2018-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22069
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -20
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16609136
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/609136 | Peptide-containing adjuvant compounds having peg spacers | Apr 24, 2018 | Issued |
Array
(
[id] => 13368695
[patent_doc_number] => 20180235888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-08-23
[patent_title] => TABLET FORMULATION COMPRISING SEMAGLUTIDE AND A DELIVERY AGENT
[patent_app_type] => utility
[patent_app_number] => 15/958236
[patent_app_country] => US
[patent_app_date] => 2018-04-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16281
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 29
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15958236
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/958236 | Tablet formulation comprising a GLP-1 peptide and a delivery agent | Apr 19, 2018 | Issued |
Array
(
[id] => 15355221
[patent_doc_number] => 10526210
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => Method of making high performance activated aluminum sesquichlorohydrate powders
[patent_app_type] => utility
[patent_app_number] => 15/950755
[patent_app_country] => US
[patent_app_date] => 2018-04-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4530
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15950755
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/950755 | Method of making high performance activated aluminum sesquichlorohydrate powders | Apr 10, 2018 | Issued |
Array
(
[id] => 15321189
[patent_doc_number] => 20200000924
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2020-01-02
[patent_title] => COMPOSITIONS CONTAINING QUATERNARY AMMONIUM COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 15/946325
[patent_app_country] => US
[patent_app_date] => 2018-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5082
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15946325
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/946325 | Methods for preparing oil-in-water emulsions comprising cetalkonium chloride | Apr 4, 2018 | Issued |
Array
(
[id] => 15321189
[patent_doc_number] => 20200000924
[patent_country] => US
[patent_kind] => A9
[patent_issue_date] => 2020-01-02
[patent_title] => COMPOSITIONS CONTAINING QUATERNARY AMMONIUM COMPOUNDS
[patent_app_type] => utility
[patent_app_number] => 15/946325
[patent_app_country] => US
[patent_app_date] => 2018-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5082
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15946325
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/946325 | Methods for preparing oil-in-water emulsions comprising cetalkonium chloride | Apr 4, 2018 | Issued |
Array
(
[id] => 17727742
[patent_doc_number] => 11384117
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-12
[patent_title] => Connective tissue stimulating peptides
[patent_app_type] => utility
[patent_app_number] => 15/938823
[patent_app_country] => US
[patent_app_date] => 2018-03-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 11845
[patent_no_of_claims] => 37
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 187
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15938823
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/938823 | Connective tissue stimulating peptides | Mar 27, 2018 | Issued |